Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
for Locally Advanced Malignant Solid Neoplasm
Drug: Durvalumab
1 location in Bethesda
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT03907475·Phase 2·Recruiting